deltatrials
Completed NA INTERVENTIONAL 3-arm NCT01424579

Diacutaneous Fibrolysis and Subacromial Syndrome

Effectiveness of Diacutaneous Fibrolysis for the Treatment of Subacromial Impingement Syndrome: a Randomised Controlled Trial

Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

Updated 6 times since 2017 Last updated: Apr 3, 2013 Started: Feb 29, 2008 Primary completion: Aug 31, 2011 Completion: Dec 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01424579, this NA trial focuses on Subacromial Impingement Syndrome and remains completed. Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Mar 2023 · 26 months · monthly snapshotCompleted~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

6 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Mar 2023 — Jul 2024 [monthly]

    Completed NA

  4. Jan 2021 — Mar 2023 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Data source: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

For direct contact, visit the study record on ClinicalTrials.gov .